Izotropic (STU:1R3) EPS (Diluted): €-0.02 (TTM As of Jan. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:1R3 Izotropic Corp STU:1R3
37 GF Score
Price €0.14
! 2 Warning Signs
View Full Analysis

What is Izotropic EPS (Diluted)?

Izotropic STU:1R3 -2.07% 37 EPS (Diluted) is €-0.02 as of Jan. 2026. GuruFocus rates STU:1R3 with a GF Score™ of 37/100. The stock has 2 warning signs investors should review.

Izotropic's Earnings per Share (Diluted) for the three months ended in Jan. 2026 was €0.00. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jan. 2026 was €-0.02.

Izotropic's EPS (Basic) for the three months ended in Jan. 2026 was €0.00. Its EPS (Basic) for the trailing twelve months (TTM) ended in Jan. 2026 was €-0.02.

Izotropic's EPS without NRI for the three months ended in Jan. 2026 was €-0.00. Its EPS without NRI for the trailing twelve months (TTM) ended in Jan. 2026 was €-0.01.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.


Izotropic  (STU:1R3) EPS (Diluted) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Izotropic EPS (Diluted) Related Terms


Izotropic EPS (Diluted) Historical Data

* Premium members only.

The historical data trend for Izotropic's EPS (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Izotropic EPS (Diluted) Chart

Izotropic Annual Data
Trend Apr17 Apr18 Apr19 Apr20 Apr21 Apr22 Apr23 Apr24 Apr25
EPS (Diluted)
Get a 7-Day Free Trial Premium Member Only -0.09 -0.11 -0.07 -0.02 -0.03

Izotropic Quarterly Data
Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26
EPS (Diluted) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.01 -0.01 -0.01 -0.01 0.00

STU:1R3 vs TMO, DHR, IDXX: EPS (Diluted) Comparison

For the Diagnostics & Research subindustry, Izotropic's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Izotropic PE Ratio vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Izotropic's PE Ratio distribution charts can be found below:

* The bar in red indicates where Izotropic's PE Ratio falls into.


STU:1R3
37GF Score
Izotropic Corp STU:1R3
EPS (Diluted) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Izotropic EPS (Diluted) Calculation

EPS (Diluted) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Diluted EPS takes into account all of the outstanding dilutive securities that could potentially be exercised (such as stock options and convertible preferred stock) and shows how such an action would impact earnings per share.

Izotropic's Diluted EPS for the fiscal year that ended in Apr. 2025 is calculated as

Diluted EPS (A: Apr. 2025 ) = (Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(-1.999-0)/58.684
=-0.03

Izotropic's Diluted EPS for the quarter that ended in Jan. 2026 is calculated as

Diluted EPS (Q: Jan. 2026 )=(Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(-0.162-0)/65.917
=-0.00

EPS (Diluted) for the trailing twelve months (TTM) ended in Jan. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €-0.02

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS (Diluted) →
What does a EPS (Diluted) of €-0.02 mean?
Izotropic (STU:1R3) has a EPS (Diluted) of €-0.02 as of Jan. 2026. Earnings per share (diluted) equals net income divided by the diluted average shares outstanding. View historical data on Izotropic and its competitors.
Is Izotropic's EPS (Diluted) too high?
Izotropic's current EPS (Diluted) is €-0.02. Overall, Izotropic has a GF Score™ of 37/100, reflecting its overall financial health beyond just this single metric.
How does Izotropic's EPS (Diluted) compare to TMO and DHR?
Izotropic's EPS (Diluted) of €-0.02 can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS (Diluted) for a Medical Diagnostics & Research company?
A good EPS (Diluted) depends on the Medical Diagnostics & Research industry context. However, EPS (Diluted) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS (Diluted) mean?
A high EPS (Diluted) can signal that a stock is expensive relative to its fundamentals. Earnings per share (diluted) equals net income divided by the diluted average shares outstanding. View historical data on Izotropic and its competitors. Izotropic's current EPS (Diluted) is €-0.02. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Izotropic stock overvalued right now?
Izotropic (STU:1R3) has a current EPS (Diluted) of €-0.02. The current EPS (Diluted) is €-0.02. Izotropic's overall GF Score™ is 37/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS (Diluted) calculated?
EPS (Diluted) is calculated from a company's financial statements. For Izotropic (STU:1R3), the current EPS (Diluted) is €-0.02 as of Jan. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Izotropic Business Description

Other Exchanges IZOZF:USAIZO:Canada
Address 800 - 15355 24th Avenue, Suite 424, Surrey, BC, CAN, V4A 2H9
Izotropic Corp is a research and development company specializing in cancer research and early detection for breast cancer. It is engaged in advancing breast cancer imaging through the commercialization of medical imaging technologies. The company's current focus is on the commercialization of its first medical imaging device, IzoView, a dedicated Breast CT Imaging System, developed to provide high resolution, true 3D volumetric visualization of the breast without compression for breast cancer detection and diagnosis.
37GF Score

Get the complete analysis for STU:1R3

EPS (Diluted) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.14
Price